CMChoo Yuen May

Choo Yuen May

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Choo Yuen May has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Afiqah Abdul Rahim

    Nutrition Unit, Product Development and Advisory Services Division, Malaysian Palm Oil Board, Bandar Baru Bangi, Selangor 43000, Malaysia

    1 shared publication
  • Augustine Soon Hock Ong

    MOSTA, C3A-10, 4th Floor, Damansara Intan, No. 1, Jalan SS20/27, Selangor 47400, Malaysia

    1 shared publication
  • Huzwah Khaza’ai

    Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia

    1 shared publication
  • Sui Kiat Chang

    Department of Allied Health Sciences, Faculty of Science, Universiti Tunku Abdul Rahman, Jalan Universiti, Bandar Barat, 31900 Kampar, Perak, Malaysia; Centre for Biomedical and Nutrition Research, Universiti Tunku Abdul Rahman, Jalan Universiti, Bandar Barat, 31900 Kampar, Perak, Malaysia

    1 shared publication
  • Zaida Zainal

    Nutrition Unit, Product Development and Advisory Technical Services Department, Malaysian Palm Oil Board, Bandar Baru Bangi, Malaysia

    1 shared publication

Latest Publications

  • Open Access

    Acute and Subchronic Oral Toxicity of Oil Palm Puree in Sprague–Dawley Rats

    by Zaida Zainal, Augustine Ong, Choo Yuen May, Sui Kiat Chang, Afiqah Abdul Rahim, Huzwah Khaza’ai

    Palm puree is rich in antioxidants and is produced via blending various proportions of mesocarp fibre and crude palm oil. The aim of this study was to assess the acute and subchronic toxicity of palm puree in male and female Sprague–Dawley rats. For the acute toxicity study, animals administered single palm-puree doses (2000 mg kg−1) by gavage were observed daily for 14 d. For the subchronic toxicity study, the rats were administered 500, 1000, or 2000 mg kg−1 palm puree daily for 28 d. We evaluated body and organ weights; performed haematological, biochemical, and histopathological analyses of blood and organ samples during and after treatment; and calculated the oral no-observed-adverse-effect level (NOAEL). The toxicity studies showed no signs of toxicity or mortality. The haematological, biochemical, and histopathological analyses and body and organ weights indicated no evidence of substantial toxicity at any dose of palm puree. The oral lethal dose and NOAEL for the palm puree were greater than 2000 mg kg−1 d−1 over 28 d. To the best of our knowledge, the present study is the first to confirm the safety of palm puree as a novel functional food. These encouraging results warrant further studies to elucidate its potential for pharmaceutical formulations.